A review of equine muscle disorders

Neuromuscular Disorders

Volumn 18, Issue 4, 2008, Pages 277-287

  Aleman, M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Equine; Exertional; Myopathy; Myotonia; Rhabdomyolysis

Indexed keywords

ALPHA TOCOPHEROL; CORTICOSTEROID; GLYCOGEN; HALOTHANE; POLYSACCHARIDE; SELENIUM; STEROID; SUXAMETHONIUM;

ALPHA TOCOPHEROL DEFICIENCY; AUTOSOMAL INHERITANCE; CUSHING DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRODIAGNOSIS; ENZYME DEFICIENCY; GENE MUTATION; GLYCOGEN BRANCHING ENZYME DEFICIENCY; GLYCOGEN STORAGE DISEASE; HISTOLOGY; HUMAN; MALIGNANT HYPERTHERMIA; MUSCLE DISEASE; MYOPATHY; MYOSITIS; MYOTONIC DYSTROPHY; NONHUMAN; PERIODIC PARALYSIS; PHENOTYPE; POLYSACCHARIDE STORAGE MYOPATHY; PRIORITY JOURNAL; PURPURA; REVIEW; RHABDOMYOLYSIS; SELENIUM DEFICIENCY; TOXIC MYOPATHY;

ANIMALS; HORSE DISEASES; HORSES; MUSCULAR DISEASES;

EID: 42649110657     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2008.01.001     Document Type: Review

References (85)

1. Valberg S.J., Mickelson J.R., Gallant E.M., MacLeay J.M., Lentz L., and De la Corte F. Exertional rhabdomyolysis in Quarter Horses and Thoroughbreds: one syndrome, multiple aetiologies. Equine Vet J Suppl 30 (1999) 533-538
2. Rudolph J.A., Spier S.J., Byrns G., Rojas C.V., Bernoco D., and Hoffman E.P. Periodic paralysis in Quarter Horses: a sodium channel mutation disseminated by selective breeding. Nat Genet 2 (1992) 144-147
3. Rudolph J.A., Spier S.J., Byrns G., and Hoffman E.P. Linkage of hyperkaelemic periodic paralysis in Quarter Horses to the horse adult skeletal muscle sodium channel gene. Anim Genet 23 (1992) 241-250
4. Aleman M., Watson J.L., Williams D.C., LeCouteur R.A., Nieto J.E., and Shelton G.D. Myopathy in horses with pituitary pars intermedia dysfunction (Cushing's disease). Neuromuscul Disord 16 (2006) 737-744
5. Lewis S.S., Valberg S.J., and Nielsen I.L. Suspected immune-mediated myositis in horses. J Vet Intern Med 21 (2007) 495-503
6. Valberg S.J., Cardinet III G.H., Carlson G.P., and DiMauro S. Polysaccharide storage myopathy associated with recurrent exertional rhabdomyolysis in horses. Neuromuscul Disord 2 (1992) 351-359
7. Ward T.L., Valberg S.J., Adelson D.L., Abbey C.A., Binns M.M., and Mickelson J.R. Glycogen branching enzyme (GBE1) mutation causing equine glycogen storage disease IV. Mamm Genome 15 (2004) 570-577
8. Aleman M., Riehl J., Aldridge B.M., Lecouteur R.A., Stott J.L., and Pessah I.N. Association of a mutation in the ryanodine receptor 1 gene with equine malignant hyperthermia. Muscle Nerve 30 (2004) 356-365
9. Dranchak P.K., Valberg S.J., Onan G.W., et al. Inheritance of recurrent exertional rhabdomyolysis in Thoroughbreds. J Am Vet Med Assoc 227 (2005) 762-767
10. Valberg S.J., Carlson G.P., Cardinet III G.H., et al. Skeletal muscle mitochondrial myopathy as a cause of exercise intolerance in a horse. Muscle Nerve 17 (1994) 305-312
11. Divers T.J., Cummings J.E., de Lahunta A., Hintz H.F., and Mohammed H.O. Evaluation of the risk of motor neuron disease in horses fed a diet low in vitamin E and high in copper and iron. Am J Vet Res 67 (2006) 120-126
12. Eisen A. Recent considerations in the etiopathogenesis of ALS. Suppl Clin Neurophysiol 57 (2004) 187-190
13. Higuchi T., Ichijo S., Osame S., and Ohishi H. Studies on serum selenium and tocopherol in white muscle disease of foal. Nippon Juigaku Zasshi 51 (1989) 52-59
14. Rayman M.P. The importance of selenium to human health. Lancet 356 (2000) 233-241
15. Lofstedt J. White muscle disease of foals. Vet Clin North Am Equine Pract 13 (1997) 169-185
16. Chariot P., and Bignani O. Skeletal muscle disorders associated with selenium deficiency in humans. Muscle Nerve 27 (2003) 662-668
17. Perkins G., Valberg S.J., Madigan J.M., Carlson G.P., and Jones S.L. Electrolyte disturbances in foals with severe rhabdomyolysis. J Vet Intern Med 12 (1998) 173-177
18. Pearson E.G., Snyder S.P., and Saulez M.N. Masseter myodegeneration as a cause of trismus or dysphagia in adult horses. Vet Rec 156 (2005) 642-646
19. DiMauro S., and Lamperti C. Muscle glycogenoses. Muscle Nerve 24 (2001) 984-999
20. Wagner M.L., Valberg S.J., Ames E.G., et al. Allele frequency and likely impact of the glycogen branching enzyme deficiency gene in Quarter Horse and Paint Horse populations. J Vet Intern Med 20 (2006) 1207-1211
21. Valberg S.J., Ward T.L., Rush B., et al. Glycogen branching enzyme deficiency in Quarter Horse foals. J Vet Intern Med 15 (2001) 572-580
22. Render J.A., Common R.S., Kennedy F.A., Jones M.Z., and Fyfe J.C. Amylopectinosis in fetal and neonatal Quarter Horses. Vet Pathol 36 (1999) 157-160
23. Annandale E.J., Valberg S.J., Mickelson J.R., and Seaquist E.R. Insulin sensitivity and skeletal muscle glucose transport in horses with equine polysaccharide storage myopathy. Neuromuscul Disord 14 (2004) 666-674
24. McCue M.E., Ribeiro W.P., and Valberg S.J. Prevalence of polysaccharide storage myopathy in horses with neuromuscular disorders. Equine Vet J Suppl 36 (2006) 340-344
25. McCue M.E., and Valberg S.J. Estimated prevalence of polysaccharide storage myopathy among overtly healthy Quarter Horses in the United States. J Am Vet Med Assoc 231 (2007) 746-750
26. Firshman A.M., Baird J.D., and Valberg S.J. Prevalences and clinical signs of polysaccharide storage myopathy and shivers in Belgian draft horses. J Am Vet Med Assoc 227 (2005) 1958-1964
27. Valentine B.A., Credille K.M., Lavoie J.P., et al. Severe polysaccharide storage myopathy in Belgian and Percheron draught horses. Equine Vet J 29 (1997) 220-225
28. Quiroz-Rothe E., Novales M., Aguilera-Tejero E., and Rivero J.L. Polysaccharide storage myopathy in the M. longissimus lumborum of showjumpers and dressage horses with back pain. Equine Vet J 34 (2002) 171-176
29. De La Corte F.D., Valberg S.J., MacLeay J.M., and Mickelson J.R. Developmental onset of polysaccharide storage myopathy in 4 Quarter Horse foals. J Vet Intern Med 16 (2002) 581-587
30. Firshman A.M., Valberg S.J., Bender J.B., and Finno C.J. Epidemiologic characteristics and management of polysaccharide storage myopathy in Quarter Horses. Am J Vet Res 64 (2003) 1319-1327
31. Valentine B.A., and Cooper B.J. Incidence of polysaccharide storage myopathy: necropsy study of 225 horses. Vet Pathol 42 (2005) 823-827
32. McCarthy E.J. Malignant hyperthermia: pathophysiology, clinical presentation, and treatment. AACN Clin Issues 15 (2004) 231-237
33. Klein L. A hot horse. Vet Anesth 2 (1975) 41-42
34. Aleman M., Brosnan R.J., Williams D.C., et al. Malignant hyperthermia in a horse anesthetized with halothane. J Vet Intern Med 19 (2005) 363-367
35. Greenbaum I., Weigl Y., and Pras E. The genetic basis of malignant hyperthermia. Isr Med Assoc J 9 (2007) 39-41
36. Fujii J., Otsu K., Zorzato F., et al. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science 253 (1991) 448-451
37. Roberts M.C., Mickelson J.R., Patterson E.E., et al. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1). Anesthesiology 95 (2001) 716-725
38. McCarthy T.V., Quane K.A., and Lynch P.J. Ryanodine receptor mutations in malignant hyperthermia and central core disease. Hum Mutat 15 (2000) 410-417
39. Paciello O., Pasolini M.P., Navas L., Russo V., and Papparella S. Myopathy with central cores in a foal. Vet Pathol 43 (2006) 579-583
40. Bowen J.N., and Craig J.F. Myoglobinuria in horses. Vet Rec 35 (1942) 354
41. Cassart D., Baise E., Cherel Y., et al. Morphological alterations in oxidative muscles and mitochondrial structure associated with equine atypical myopathy. Equine Vet J 39 (2007) 26-32
42. Votion D.M., Linden A., Saegerman C., et al. History and clinical features of atypical myopathy in horses in Belgium (2000-2005). J Vet Intern Med 21 (2007) 1380-1391
43. Whitwell K.E., Harris P., and Farrington P.G. Atypical myoglobinuria: an acute myopathy in grazing horses. Equine Vet J 20 (1988) 357-363
44. Pope D.C., and Heslop C.H. An outbreak of myoglobinuria in light horses. Can Vet J 1 (1960) 171-174
45. Finno C.J., Valberg S.J., Wunschmann A., and Murphy M.J. Seasonal pasture myopathy in horses in the midwestern United States: 14 cases (1998-2005). J Am Vet Med Assoc 229 (2006) 1134-1141
46. Briani C., Doria A., Sarzi-Puttini P., and Dalakas M.C. Update on idiopathic inflammatory myopathies. Autoimmunity 39 (2006) 161-170
47. Sponseller B.T., Valberg S.J., Tennent-Brown B.S., Foreman J.H., Kumar P., and Timoney J.F. Severe acute rhabdomyolysis associated with Streptococcus equi infection in four horses. J Am Vet Med Assoc 227 (2005) 1800-1807 [753-4]
48. Kaese H.J., Valberg S.J., Hayden D.W., et al. Infarctive purpura hemorrhagica in five horses. J Am Vet Med Assoc 226 (2005) 1893-1898
49. Peek S.F., Semrad S.D., and Perkins G.A. Clostridial myonecrosis in horses (37 cases 1985-2000). Equine Vet J 35 (2003) 86-92
50. Brown E.J. The molecular basis of streptococcal toxic shock syndrome. N Engl J Med 350 (2004) 2093-2094
51. Alouf J.E., and Muller-Alouf H. Staphylococcal and Streptococcal superantigens: molecular, biological and clinical aspects. Int J Med Microbiol 292 (2003) 429-440
52. Pusterla N., Watson J.L., Affolter V.K., Magdesian K.G., Wilson W.D., and Carlson G.P. Purpura haemorrhagica in 53 horses. Vet Rec 153 (2003) 118-121
53. van der Boon F., and Groeneweg M. Acute abdominal pain as the first sign of Henoch-Schonlein purpura: a hidden diagnosis in the absence of purpura. Ned Tijdschr Geneeskd 149 (2005) 2522-2526
54. Figarella-Branger D., Civatte M., Bartoli C., and Pellissier J.F. Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies. Muscle Nerve 28 (2003) 659-682
55. Evans J., Levesque D., and Shelton G.D. Canine inflammatory myopathies: a clinicopathologic review of 200 cases. J Vet Intern Med 18 (2004) 679-6791
56. Pumarola M., Moore P.F., and Shelton G.D. Canine inflammatory myopathy: analysis of cellular infiltrates. Muscle Nerve 29 (2004) 782-789
57. Schott II H.C. Pituitary pars intermedia dysfunction: equine Cushing's disease. Vet Clin North Am Equine Pract 18 (2002) 237-270
58. McFarlane D. Advantages and limitations of the equine disease, pituitary pars intermedia dysfunction as a model of spontaneous dopaminergic neurodegenerative disease. Ageing Res Rev 6 (2007) 54-63
59. MacLeay J.M., Sorum S.A., Valberg S.J., Marsh W.E., and Sorum M.D. Epidemiologic analysis of factors influencing exertional rhabdomyolysis in Thoroughbreds. Am J Vet Res 60 (1999) 1562-1566
60. McGowan C.M., Fordham T., and Christley R.M. Incidence and risk factors for exertional rhabdomyolysis in Thoroughbred racehorses in the United Kingdom. Vet Rec 151 (2002) 623-626
61. Ward T.L., Valberg S.J., Gallant E.M., and Mickelson J.R. Calcium regulation by skeletal muscle membranes of horses with recurrent exertional rhabdomyolysis. Am J Vet Res 61 (2000) 242-247
62. Lentz L.R., Valberg S.J., Herold L.V., Onan G.W., Mickelson J.R., and Gallant E.M. Myoplasmic calcium regulation in myotubes from horses with recurrent exertional rhabdomyolysis. Am J Vet Res 63 (2002) 1724-1731
63. Mlekoday J.A., Mickelson J.R., Valberg S.J., Horton J.H., Gallant E.M., and Thompson L.V. Calcium sensitivity of force production and myofibrillar ATPase activity in muscles from Thoroughbreds with recurrent exertional rhabdomyolysis. Am J Vet Res 62 (2001) 1647-1652
64. Dranchak P.K., Valberg S.J., Onan G.W., et al. Exclusion of linkage of the RYR1, CACNA1S, and ATP2A1 genes to recurrent exertional rhabdomyolysis in Thoroughbreds. Am J Vet Res 67 (2006) 1395-1400
65. Collinder E., Lindholm A., and Rasmuson M. Genetic markers in Standardbred trotters susceptible to the rhabdomyolysis syndrome. Equine Vet J 29 (1997) 117-120
66. Lentz L.R., Valberg S.J., Balog E.M., Mickelson J.R., and Gallant E.M. Abnormal regulation of muscle contraction in horses with recurrent exertional rhabdomyolysis. Am J Vet Res 60 (1999) 992-999
67. McKenzie E.C., Valberg S.J., Godden S.M., et al. Plasma and urine electrolyte and mineral concentrations in Thoroughbred horses with recurrent exertional rhabdomyolysis after consumption of diets varying in cation-anion balance. Am J Vet Res 63 (2002) 1053-1060
68. McKenzie E.C., Valberg S.J., Godden S.M., et al. Effect of dietary starch, fat, and bicarbonate content on exercise responses and serum creatine kinase activity in equine recurrent exertional rhabdomyolysis. J Vet Intern Med 17 (2003) 693-701
69. Taylor R.W., Schaefer A.M., Barron M.J., McFarland R., and Turnbull D.M. The diagnosis of mitochondrial muscle disease. Neuromuscul Disord 14 (2004) 237-245
70. Spier S.J., Carlson G.P., Holliday T.A., Cardinet III G.H., and Pickar J.G. Hyperkalemic periodic paralysis in horses. J Am Vet Med Assoc 197 (1990) 1009-1017
71. Cox J.H., and De Bowes R.M. Episodic weakness caused by hyperkalemic periodic paralysis in horses. Compend Contin Educ Pract Vet 12 (1990) 83-89
72. Bowling A.T., Byrns G., and Spier S. Evidence for a single pedigree source of the hyperkalemic periodic paralysis susceptibility gene in Quarter Horses. Anim Genet 27 (1996) 279-281
73. Pickar J.G., Spier S.J., Snyder J.R., and Carlsen R.C. Altered ionic permeability in skeletal muscle from horses with hyperkalemic periodic paralysis. Am J Physiol 260 (1991) C926-C933
74. Meyer T.S., Fedde M.R., Cox J.H., and Erickson H.H. Hyperkalaemic periodic paralysis in horses: a review. Equine Vet J 31 (1999) 362-367
75. Carr E.A., Spier S.J., Kortz G.D., and Hoffman E.P. Laryngeal and pharyngeal dysfunction in horses homozygous for hyperkalemic periodic paralysis. J Am Vet Med Assoc 209 (1996) 798-803
76. Waldridge B., Lin H., and Purohit R. Anesthetic management of horses with hyperkalemic periodic paralysis. Compend Contin Educ Pract Vet 18 (1996) 1030-1038
77. Sah R.L., Tsushima R.G., and Backx P.H. Effects of local anesthetics on Na+ channels containing the equine hyperkalemic periodic paralysis mutation. Am J Physiol 275 (1998) C389-C400
78. Reynolds A.J., Potter G.D., Greene L.W., et al. Genetic-diet interactions in the hyperkalemic periodic paralysis syndrome in Quarter Horses fed varying amounts of potassium: III. The relationship between plasma potassium concentration and HYPP symptoms. J Equine Vet Sci 18 (1998) 731-735
79. Hegreberg G.A., and Reed S.M. Skeletal muscle changes associated with equine myotonic dystrophy. Acta Neuropathol 80 (1990) 426-431
80. Reed S.M., Hegreberg G.A., Bayly W.M., Brown C.M., Paradis M.R., and Clemmons R.M. Progressive myotonia in foals resembling human dystrophia myotonica. Muscle Nerve 11 (1988) 291-296
81. Montagna P., Liguori R., Monari L., et al. Equine muscular dystrophy with myotonia. Clin Neurophysiol 112 (2001) 294-299
82. Shirakawa T., Ide M., Taniyama H., et al. Muscular dystrophy-like disease in a Thoroughbred foal. J Comp Pathol 100 (1989) 287-294
83. Logigian E.L., Ciafaloni E., Quinn L.C., et al. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy. Muscle Nerve 35 (2007) 479-485
84. Brook J.D., McCurrach M.E., Harley H.G., et al. Molecular basis of myotonic dystrophy: expansion of a trinucleiotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68 (1992) 799-808
85. Liquori C.L., Ricker K., Moseley M.L., et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293 (2001) 864-867